Cabot Wealth Management Inc. purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 1,273 shares of the healthcare conglomerate’s stock, valued at approximately $474,000.
A number of other large investors have also recently bought and sold shares of UNH. Trust Asset Management LLC raised its holdings in UnitedHealth Group by 80.8% during the 3rd quarter. Trust Asset Management LLC now owns 4,810 shares of the healthcare conglomerate’s stock valued at $1,500,000 after buying an additional 2,150 shares during the last quarter. Wealth Alliance raised its holdings in UnitedHealth Group by 6.5% in the 3rd quarter. Wealth Alliance now owns 7,371 shares of the healthcare conglomerate’s stock worth $2,298,000 after purchasing an additional 453 shares in the last quarter. OLD Mission Capital LLC bought a new position in UnitedHealth Group in the 3rd quarter worth $439,000. IHT Wealth Management LLC raised its holdings in UnitedHealth Group by 35.5% in the 3rd quarter. IHT Wealth Management LLC now owns 4,547 shares of the healthcare conglomerate’s stock worth $1,418,000 after purchasing an additional 1,191 shares in the last quarter. Finally, Kingsview Wealth Management LLC raised its holdings in UnitedHealth Group by 15.5% in the 3rd quarter. Kingsview Wealth Management LLC now owns 8,768 shares of the healthcare conglomerate’s stock worth $2,734,000 after purchasing an additional 1,177 shares in the last quarter. Institutional investors own 86.03% of the company’s stock.
Shares of NYSE:UNH opened at $396.54 on Friday. The firm’s 50 day moving average price is $367.37 and its 200-day moving average price is $345.20. UnitedHealth Group Incorporated has a twelve month low of $273.71 and a twelve month high of $401.48. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $374.86 billion, a PE ratio of 22.78, a price-to-earnings-growth ratio of 1.55 and a beta of 0.74.
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 23rd. Shareholders of record on Monday, March 15th were paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.26%. The ex-dividend date of this dividend was Friday, March 12th. UnitedHealth Group’s payout ratio is 33.09%.
In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, April 19th. The shares were sold at an average price of $391.25, for a total transaction of $978,125.00. Following the sale, the director now owns 154,181 shares in the company, valued at approximately $60,323,316.25. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Patricia L. Lewis sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, April 16th. The stock was sold at an average price of $389.99, for a total transaction of $1,169,970.00. Following the sale, the executive vice president now owns 9,214 shares in the company, valued at approximately $3,593,367.86. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,119 shares of company stock worth $5,440,869. 0.80% of the stock is owned by company insiders.
Several research analysts have commented on the stock. Truist Securities upped their price objective on shares of UnitedHealth Group from $420.00 to $450.00 and gave the stock a “buy” rating in a report on Tuesday. Bank of America restated a “buy” rating and issued a $415.00 price objective on shares of UnitedHealth Group in a report on Thursday, January 21st. Truist upped their target price on shares of UnitedHealth Group from $420.00 to $450.00 in a research report on Wednesday, April 14th. Argus raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $450.00 target price on the stock in a research report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $409.00 to $418.00 and gave the stock a “buy” rating in a research report on Thursday. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $409.61.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
Read More: Trading based on a resistance level
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.